Balance Sheet Data
Novo Nordisk A/S (NVO)
$97.59
-2.04 (-2.05%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 15,638 | 15,475 | 12,757 | 17,485 | 23,574 | 24,851.99 | 27,942.27 | 31,416.83 | 35,323.43 | 39,715.81 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 26,889 | 29,152 | 32,184 | 46,799 | 57,505 | 55,319.37 | 62,198.19 | 69,932.39 | 78,628.30 | 88,405.54 |
| Account Receivables (%) | ||||||||||
| Inventories | 16,336 | 17,641 | 18,536 | 19,621 | 24,388 | 28,404.83 | 31,936.91 | 35,908.18 | 40,373.27 | 45,393.59 |
| Inventories (%) | ||||||||||
| Accounts Payable | 6,756 | 6,358 | 5,717 | 8,870 | 15,587 | 12,281.09 | 13,808.21 | 15,525.22 | 17,455.75 | 19,626.33 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -12,410 | -11,231 | -22,081 | -7,385 | -14,753 | -20,404.11 | -22,941.31 | -25,794.01 | -29,001.43 | -32,607.69 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.